Efficacy assessment of pemetrexed treatment of an NSCLC case with brain metastasis.

Item

http://www.wikidata.org/entity/Q41115642

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Efficacy assessment of pemetrexed treatment of an NSCLC case with brain metastasis.

@en

type

Item

label

Efficacy assessment of pemetrexed treatment of an NSCLC case with brain metastasis.

@en

prefLabel

Efficacy assessment of pemetrexed treatment of an NSCLC case with brain metastasis.

@en

P1476

Efficacy assessment of pemetrexed treatment of an NSCLC case with brain metastasis.

@en

P2093

Beibei Yin

http://www.w3.org/2001/XMLSchema#string

Hairong Liu

http://www.w3.org/2001/XMLSchema#string

Jing Liang

http://www.w3.org/2001/XMLSchema#string

Junjuan Xiao

http://www.w3.org/2001/XMLSchema#string

Xiaolin Liu

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

P2860

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer

Treatment of brain metastasis from lung cancer.

Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib.

Second-line treatment of stage III/IV non-small-cell lung cancer (NSCLC) with pemetrexed in routine clinical practice: evaluation of performance status and health-related quality of life.

Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy.

Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain.

Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer.

Distribution of the novel antifolate pemetrexed to the brain.

Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clini

Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamo

P304

1119-1121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2012.888

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233539851

http://www.w3.org/2001/XMLSchema#string

P698

23162663

http://www.w3.org/2001/XMLSchema#string

P932

3499519

http://www.w3.org/2001/XMLSchema#string